SEQUENOM INC

Profile

Company Names

SEQUENOM INC

Addresses

3595 JOHN HOPKINS COURT, SAN DIEGO, X1 92121

3595 JOHN HOPKINS CT, SAN DIEGO, CA 92121

3595 JOHN HOPKINS COURT, SAN DIEGO, CA 92121, SAN DIEGO, CA 92121

Phone Numbers

8582029000
(858) 202-9000

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$268,117,265.00

Number of Funding Rounds:

4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2015-06-09 
$85,000,000.00 
$85,000,000.00 
$0.00 
Debt 
3
2012-09-17 
$130,000,000.00 
$130,000,000.00 
$0.00 
Debt 
2
2010-05-17 
$51,605,250.00 
$51,605,250.00 
$0.00 
Equity 
1
2009-12-21 
$1,512,015.00 
$1,512,015.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
ERNST-GUNTER 
 
AFTING 
DIRECTOR
SEQUENOM INC   |  SORRENTO THERAPEUTICS, INC.
CAROLYN 
 
BEAVER 
EXECUTIVE OFFICER
SEQUENOM INC   |  SONENDO, INC.
ALLEN 
T. 
BOMBARD 
EXECUTIVE OFFICER
SEQUENOM INC
KENNETH 
F. 
BUECHLER 
DIRECTOR
SEQUENOM INC
CHARLES 
R. 
CANTOR 
EXECUTIVE OFFICER, DIRECTOR
SEQUENOM INC
JOHN 
A. 
FAZIO 
DIRECTOR
SEQUENOM INC
DANIEL 
S. 
GROSU 
EXECUTIVE OFFICER
SEQUENOM INC
HARRY 
F. 
HIXSON 
EXECUTIVE OFFICER, DIRECTOR
SEQUENOM INC
ALISA 
 
JUDGE 
EXECUTIVE OFFICER
SEQUENOM INC
MYLA 
 
LAI-GOLDMAN 
DIRECTOR
CANCERGUIDE DIAGNOSTICS, INC.   |  GENECENTRIC DIAGNOSTICS, INC.   |  SEQUENOM INC   |  GENECENTRIC THERAPEUTICS, INC.
RICHARD 
A. 
LERNER 
DIRECTOR
XENCOR INC   |  OPKO HEALTH, INC.   |  SEQUENOM INC   |  ZEBRA BIOLOGICS, INC.
RONALD 
M. 
LINDSAY 
EXECUTIVE OFFICER, DIRECTOR
SEQUENOM INC   |  ZEBRA BIOLOGICS, INC.
JEFF 
 
LINTON 
EXECUTIVE OFFICER
SEQUENOM INC   |  LIFE BOOST LLC   |  LIFE BOOST INC.
PAUL 
 
MAIER 
EXECUTIVE OFFICER
SEQUENOM INC   |  PURE BIOSCIENCE, INC.   |  INTERNATIONAL STEM CELL CORP   |  TELIK INC   |  MABVAX THERAPEUTICS INC   |  MABVAX THERAPEUTICS HOLDINGS, INC.   |  BIOLOGICAL DYNAMICS INC   |  CONVERGEONE HOLDINGS, INC.
SHAWN 
 
MARCELL 
EXECUTIVE OFFICER
SEQUENOM INC   |  READ COOR, INC.   |  KINNOS INC.   |  TORUS BIOSYSTEMS, INC.   |  AIXMED, INC.
ALEXANDER 
 
MONKO 
EXECUTIVE OFFICER
SEQUENOM INC
LARRY 
 
MYRES 
EXECUTIVE OFFICER
SEQUENOM INC   |  SCIENTIA VASCULAR, INC.
CLARKE 
 
NEUMANN 
EXECUTIVE OFFICER
SEQUENOM INC   |  PROGENITY, INC.
DAVID 
 
PENDARVIS 
DIRECTOR
SEQUENOM INC
GARY 
 
RIORDAN 
EXECUTIVE OFFICER
SEQUENOM INC   |  NANOSTRING TECHNOLOGIES INC
CHARLES 
 
SLACIK 
DIRECTOR
SEQUENOM INC
DIRK 
 
VAN DEN BOOM 
EXECUTIVE OFFICER, DIRECTOR
SEQUENOM INC   |  JUNO DIAGNOSTICS, INC.   |  VAN DEN BOOM VENTURES LLC
ROBIN 
 
WEINER 
EXECUTIVE OFFICER
SEQUENOM INC
WILLIAM 
 
WELCH 
EXECUTIVE OFFICER, DIRECTOR
CLARABRIDGE INC   |  SEQUENOM INC   |  TROVAGENE, INC.   |  IRONNET CYBERSECURITY, INC.
KATHLEEN 
W. 
WILTSEY 
DIRECTOR
SEQUENOM INC
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2015-06-19
D
Link
BIOTECHNOLOGY 
MEASURING + CONTROLLING DEVICES, NEC [3829] 
DECLINE TO DISCLOSE 
Debt 
2015-06-09 
2012-09-24
D
Link
BIOTECHNOLOGY 
MEASURING + CONTROLLING DEVICES, NEC [3829] 
DECLINE TO DISCLOSE 
Debt 
2012-09-17 
2010-05-24
D
Link
BIOTECHNOLOGY 
MEASURING + CONTROLLING DEVICES, NEC [3829] 
$25,000,001 - $100,000,000 
Equity 
2010-05-17 
2009-12-29
D
Link
BIOTECHNOLOGY 
MEASURING + CONTROLLING DEVICES, NEC [3829] 
$25,000,001 - $100,000,000 
Equity 
2009-12-21 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
LAZARD FERES + CO.
2528
JEFFERIES + COMPANY, INC.
2347
JEFFERIES + COMPANY, INC.
2347
LAZARD CAPITAL MARKETS LLC
134736
LAZARD CAPITAL MARKETS LLC
134736